Reata Pharmaceuticals, Inc. (Nasdaq: RETA) announced that it has filed a registration statement on Form S-1 with the U.S. Securities ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE